highperformr logo

Alkermes's Overview

Total employees2237
HeadquartersDublin 4
Founded1987

Alkermes plc is a fully integrated, global biopharmaceutical company committed to developing innovative medicines for the treatment of central nervous system (CNS) diseases and cancer. The company has a diverse portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder, alongside a pipeline of R&D programs in neuroscience and oncology. Alkermes leverages its scientific expertise and proprietary technologies to address unmet medical needs and improve patient outcomes.

Where is Alkermes's Headquarters?

HQ Function

The Dublin headquarters serves as the central corporate and administrative hub, overseeing global strategy, finance, legal affairs, and international commercial operations.

Notable Features:

Located in a modern office building in a key business district, designed to support corporate functions and global management.

Work Culture:

The headquarters fosters a collaborative and performance-driven work environment, reflecting Alkermes' commitment to innovation and addressing serious medical conditions. It connects global teams focused on patient care.

HQ Significance:

Its Irish headquarters underscores Alkermes' global operational structure and provides strategic access to European markets and regulatory bodies. Ireland's established pharmaceutical sector also offers a supportive business environment.

Values Reflected in HQ: The headquarters' location and function reflect Alkermes' global vision, commitment to operational excellence, and strategic positioning within the international pharmaceutical landscape.

Location:

Alkermes operates with a global footprint, anchored by its corporate headquarters in Dublin, Ireland. Key operational, research, and manufacturing functions are distributed across strategic locations in the United States (Waltham, Massachusetts, and Wilmington, Ohio) and Ireland (Athlone). These facilities collectively support the company's end-to-end capabilities, from drug discovery and development to manufacturing and commercialization of medicines for patients worldwide, primarily in the fields of neuroscience and oncology.

Street Address:

Connaught House, 1 Burlington Road

City:

Dublin 4

State/Province:

Dublin

Country:

Ireland

Alkermes's Global Presence

Waltham, Massachusetts, USA

Address: 852 Winter Street, Waltham, MA 02451, USA

Drives innovation through cutting-edge R&D, supports clinical development programs, and manages U.S. commercialization efforts for Alkermes' portfolio.

Wilmington, Ohio, USA

Address: 301 E. Mulberry Street, Wilmington, OH 45177, USA

Ensures the reliable supply and high-quality production of Alkermes' medicines for the U.S. and global markets, playing a critical role in the company's supply chain.

Athlone, Co. Westmeath, Ireland

Address: Monksland Industrial Estate, Athlone, Co. Westmeath, Ireland

Supports global product development and manufacturing, particularly for advanced drug delivery systems. It leverages Ireland's strong pharmaceutical talent pool and infrastructure.

Buying Intent Signals for Alkermes

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Alkermes

As of April 2025, Alkermes' leadership includes:

Richard F. Pops - Chairman and Chief Executive Officer
Iain M. Brown - Chief Financial Officer
Craig S. Hopkinson, M.D. - Chief Medical Officer and Executive Vice President, Research & Development
Mark S. Stejbach - Chief Commercial Officer
Blair C. Volckmann - Executive Vice President, Corporate Development and Chief Legal Officer
Heather L. Faulds - Senior Vice President, Human Resources
Madelyn H. Zeylikman - Senior Vice President, Operations and Quality

Investors of Alkermes

Alkermes has been backed by several prominent investors over the years, including:

The Vanguard Group, Inc.
BlackRock, Inc.
PRIMECAP Management Company
State Street Corporation
FMR LLC (Fidelity Management & Research)

Executive New Hires/Exits in the Last 12 Months

Hire5
Exits3

Alkermes executed a significant leadership transition in late 2023 and early 2024, appointing new executives to critical roles including Chief Commercial Officer, Chief Legal Officer, SVP Human Resources, and SVP Operations & Quality, primarily effective January 2024. This was complemented by the earlier appointment of a new Chief Medical Officer in May 2023. These changes also included the departures of the former Chief Commercial Officer, Chief Legal Officer, and Chief Operating Officer at the end of 2023.

Departures

Todd Nichols, Todd Nichols departed his role as Chief Commercial Officer at the end of 2023, as part of a planned leadership transition.
Peter Lowry, Peter Lowry departed his role as Chief Legal Officer and EVP, Corporate Development at year-end 2023, following a transition period.
Sandy Coombs, Sandy Coombs, former Chief Operating Officer, left the company at the end of 2023.

New Appointments:

Craig S. Hopkinson, M.D., Dr. Craig S. Hopkinson was appointed to lead Alkermes' global research and development functions.
Blair C. Volckmann, Blair C. Volckmann joined Alkermes to oversee corporate development strategy and lead the legal department.
Mark S. Stejbach, Mark S. Stejbach was appointed to lead Alkermes' global commercial organization and strategy.
Heather L. Faulds, Heather L. Faulds was appointed to lead the global human resources function at Alkermes.
Madelyn H. Zeylikman, Madelyn H. Zeylikman was appointed to lead global operations and quality assurance for Alkermes.

Technology (Tech Stack) used by Alkermes

Discover the tools Alkermes uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Alkermes Email Formats and Examples

Alkermes plc typically utilizes a standard corporate email format. The most common structure is 'first.last@alkermes.com'. Variations such as 'first_initiallast@alkermes.com' might also be in use for some employees or specific circumstances.

first.last@alkermes.com

Format

jane.doe@alkermes.com

Example

85%

Success rate

News and media

Business WireApril 24, 2024

Alkermes Reports Strong First Quarter 2024 Financial Results and Raises Full Year Guidance

Alkermes plc announced its financial results for the first quarter of 2024, reporting total revenues of $379.8 million. The company also raised its full-year 2024 financial expectations, driven by strong performance of its proprietary products....more

Alkermes Official WebsiteMay 6, 2024

Alkermes Showcases New Clinical and Real-World Data for LYBALVI® and ARISTADA® Franchise at APA Annual Meeting

Alkermes plc announced it will present 12 posters featuring new clinical and real-world data for LYBALVI® (olanzapine and samidorphan) and its ARISTADA® (aripiprazole lauroxil) product family at the American Psychiatric Association (APA) Annual Meeting, held May 4-8, 2024, in New York City....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Alkermes, are just a search away.